Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On February 24, 2026, Palvella Therapeutics, Inc. (the “ Company ”) issued a press release announcing positive topline results from the Company’s
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release issued by Palvella Therapeutics, Inc. on February 24, 2026* 104 Cover